Sept. 18, 2007 - Generex Biotechnology Corporation (NasdaqCM:GNBT), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, announced that it will be making a podium presentation at the 43rd Annual Meeting of the European Society Association for the Study of Diabetes (EASD) in Amsterdam, The Netherlands, September 17 - 21, 2007.... The technology used by Professor Pozzilli's group, developed at Antigen Express, facilitates detection of autoimmune responses that underlie Type-1 Diabetes Mellitus... Generex 's press Release -
